Related Experiment Video

Updated: Jun 2, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

Acute liver failure in children

Denis Devictor1, Pierre Tissieres, Mickael Afanetti

  • 1Neonatal, Pediatric Intensive Care Unit, Department of Pediatrics, AP-HP, Bicêtre Hospital, Paris 11-Sud University, 78, avenue Général-Leclerc, 94275 Le Kremlin-Bicêtre, France. denis.devictor@bct.aphp.fr

Clinics and Research in Hepatology and Gastroenterology
|May 3, 2011
PubMed

Insights

Managing pediatric acute liver failure requires a team approach. While liver transplantation is often definitive, hepatocyte transplantation shows promise for bridging or treating metabolic liver diseases.

Area of Science:

  • Pediatric Hepatology
  • Gastroenterology
  • Transplantation Medicine

Background:

  • Acute liver failure in children necessitates intensive, multidisciplinary care.
  • Research on medical therapies for pediatric acute liver failure lags behind adult studies.
  • Definitive treatment for pediatric acute liver failure is often liver transplantation.

Purpose of the Study:

  • To review current management strategies for pediatric acute liver failure.
  • To explore the potential role of hepatocyte transplantation in pediatric liver disease.
  • To assess hepatocyte transplantation as a bridge to liver transplant or alternative therapy.

Main Methods:

  • Literature review of recent clinical studies on pediatric acute liver failure.
  • Analysis of data regarding medical and surgical interventions.
  • Evaluation of outcomes for hepatocyte transplantation in pediatric patients.

Main Results:

  • Limited specific medical therapies exist for pediatric acute liver failure, barring certain metabolic conditions.
  • Liver transplantation remains the primary definitive treatment.
  • Hepatocyte transplantation is emerging as a viable option for bridging patients or managing specific metabolic liver diseases.

Conclusions:

  • Hepatocyte transplantation offers a promising therapeutic avenue in pediatric acute liver failure.
  • It may serve as a bridge to liver transplantation or an alternative in select metabolic disorders.
  • Further research is warranted to optimize hepatocyte transplantation protocols for children.

More Related Videos

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube06:12

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube

Published on: April 28, 2020

Cell Type-specific Gene Expression Profiling in the Mouse Liver10:06

Cell Type-specific Gene Expression Profiling in the Mouse Liver

Published on: September 17, 2019

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...